Objectives: Inflammatory markers and impaired renal function are the predictors of adverse outcome in patients with peripheral arterial disease (PAD). Despite interrelated pathophysiology between inflammation, platelets and renal function, these risk factors have not been examined together in the clinical setting. Therefore, the purpose of the study was to investigate their prognostic impact in PAD patients and to verify if they could add to the prognostic power of the ankle/brachial index (ABI).
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/L), MPV (>7.7 fL) and eGFR (<60 ml/min) to predict MACE were calculated with ROC analysis. Comparison between c-statistics was made to assess the better ability of biomarkers in combination with ABI vs. ABI alone to predict MACE in PAD patients. 
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